The growing popularity and rising demand for peptide-based drugs, specifically the GLP-1 peptide drugs, have garnered the attention of stakeholders to further invest in research and developments of peptides. Peptides represent one of the fastest growing segments of the pharmaceutical industry. This can be attributed to the rapidly growing pipeline of peptide-based therapeutics, driven by the...